Non-invasive and radiation-free assessment for early rule-out of CAD.
On a Mission to Listen to Millions of Hearts
Introducing CADScor®System — an AI-powered acoustic diagnostic aid to rule out coronary artery disease in 10 minutes.*
Use CADScor®System to Rule-Out CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Can help save costs of more advanced CAD diagnostics in up to 35% of patients.¹
Rapid and easy-to-use, with clear results in 10 minutes.
Rule-Out CAD in Just 10 Minutes with 96% Confidence¹
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.² In just 10 minutes, it calculates a patient-specific CAD-score, indicating the patient’s risk of coronary stenosis. CADScor®System has been used in 20,000 patient assessments³ and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®System
Explore customer feedbackSchedule a Demo of CADScor®System
Schedule a free demo of CADScor®System and learn how to rule out low-risk CAD patients in 10 minutes.
Latest News
See all news
Jul 4, 2022
Samuel Schmidt, Co-founder at Acarix has received the Danish MedTech Society’s Rosenfalck Prize.
May 12, 2022
Acarix at Naventus Health Care Summit 2022.
March 3, 2022
CADScor®System recognized as Most Innovative Coronary Artery Disease Analytical Device 2021.
- US user manual v.12.5, prevalence 10,7%, algorithm version US3.2
- Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
- Based on commercial patch use since 2017